BORTEZOMIB J Code: J9044

Drug & Product Overview

HCPCS Descriptor Injection, bortezomib, not otherwise specified, 0.1 mg

HCPCS Added Date January 1, 2019

Manufacturer Multiple Manufacturers

Route of Administration Intravenous, Subcutaneous

Generic Status HCPCS Discontinued

Dosage Type Single-Dose

Dosage Form Injection, Powder, Lyophilized, For Solution | Not Available

About BORTEZOMIB

Bortezomib is a medication aligned to the HCPCS J Code: J9044 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous or subcutaneous routes and manufactured by multiple companies.

Manufacturers, reach out to us to add more information.

NDC Code Information

5 NDC packages are crosswalked to J9044. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	BORTEZOMIB
	BORTEZOMIB
	BORTEZOMIB
	BORTEZOMIB

Login to view 5 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

BORTEZOMIB CPT Administration Codes

CPT Code	Description
96401	Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
96409	Chemotherapy administration; intravenous, push technique, single or initial substance/drug
96413 Login for More	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug Login for More
96415 Login for More	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure) Login for More

Not on the CMS JW / JZ list

CMS does not include Bortezomib (J9044) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9044. Wastage billing guide →

BORTEZOMIB Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Mantle Cell Lymphoma Multiple Myeloma

Drug Class

Proteasome Inhibitor [EPC]Proteasome Inhibitors [MoA]

Frequently Asked Questions

Is there an available Bortezomib billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for BORTEZOMIB.

Are there any available Bortezomib patient assistance programs?

Our team has not identified a manufacturer-published source of patient assistance information for BORTEZOMIB.

Where can I find Bortezomib prescribing information?

BORTEZOMIB prescribing information can be found at the link below: Visit Here →

Where can I find Bortezomib side effect information?

Information regarding BORTEZOMIB's side effects can be found at MedlinePlus Visit Here →

Does billing BORTEZOMIB require JZ/JW wastage modifiers?

CMS does not include BORTEZOMIB (J9044) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9044. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.